CD-Venture

CD-Venture

Heidelberg, Germany
Is it you?
Investor info
Type
Venture Capital
Stage focus
  • Seed Round,
  • Early stage VC,
  • Later stage VC
Industry focus
Description
CD-Venture GmbH is a German venture capital firm based in Heidelberg, Baden-Wurttemberg, Germany, specialising in life-sciences-sector investments. Heidelberg is one of Germany's major biomedical-research cities aEUR" home to the University of Heidelberg, Heidelberg University Hospital, the European Molecular Biology Laboratory (EMBL), the Max Planck Institute for Medical Research, and the German Cancer Research Center (DKFZ). CD-Venture operates alongside other German / European life-sciences VCs such as HTGF (covered earlier), Wellington Partners, TVM Capital, Forbion, and Sofinnova Partners. Detailed public information including precise aggregate AUM in EUR denominations, named general partners, BaFin regulatory-registration status, fund vintages, and comprehensive portfolio-company disclosures is partially documented in mainstream German / European biotech-industry databases for this specific URL. The row should be noted as Active with moderate disclosure.
Previous investments
  • Company
    Amount
    Round
  • Example example company Inc
    1000000
    Investor meetings
  • Company & Company
    11000000
    Series C funding
  • Example
    524000
    Seed round A
Show more
Connected people
Email visible after logging in
  • Example Example
    Example Exampleexample[email protected]
  • Example Exampleexample
    Example Exampleexample
  • Notexample Examplenot
    Notexample Examplenotexample example[email protected]
  • Example Examplenotexample
    Example Examplenotexampleexample example[email protected]
  • Example Example
    Example Exampleexample[email protected]
  • Example Example
    Example Exampleexample[email protected]
Show more
See other investors focused on
Life Sciences
Other investors you may be interested in
Made with in San Francisco, Berlin, Valencia, Oslo, Cherkasy and Warsaw© 2015-     Foundersuite, Inc.